Avid Bioservices Inc banner

Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.49 USD 0.08% Market Closed
Market Cap: $801.1m

Avid Bioservices Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avid Bioservices Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other
$47m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other
-$6.5B
CAGR 3-Years
-244%
CAGR 5-Years
-115%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Other
-$10.9B
CAGR 3-Years
-372%
CAGR 5-Years
-161%
CAGR 10-Years
-34%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other
-$371.2m
CAGR 3-Years
-30%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other
-$276.6m
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
2%
No Stocks Found

Avid Bioservices Inc
Glance View

Market Cap
801.1m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
6.04 USD
Overvaluation 52%
Intrinsic Value
Price

See Also

Back to Top